home > ict > autumn 2017 > the connected ctms


Dear guest!
To access full content of this article, please take a minute to become a member of this site. As a registered user you will be able to view all of our vast archive's material at any time. Sign up now!

       Already registered? Please sign in.

Alternatively, please use our pay-per-view service.


News and Press Releases

Acino Signs Exclusive License Agreement With Bioprojet for Treatment of Narcolepsy and Obstructive Sleeping Apnoea (OSA)

ZURICH, Switzerland, 14 June 2022 Acino, a Swiss pharmaceutical company headquartered in Zurich, announced today that it has signed an exclusive licensing agreement with Bioprojet, a French research-based pharmaceutical company, to register, market, commercialise, and distribute pitolisant in the Kingdom of Saudi Arabia (KSA), with potential expansion to other countries in the Middle East.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement